Keywords: Jazz Pharma, USA, FDA, Date-rape drug, Sodium oxybate, Rekinla, Xyrem, Fibromyalgia

US FDA panel says overwhelming “no” to using Jazz Pharma’s date-rape type drug for fibromyalgia

Article | 23 August 2010

Print This

The Joint Advisory Committee of the US Food and Drug Administration, including the Arthritis Advisory Committee and the Drug Safety ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in